Membrane effects of drugs interfering with adrenergic mechanisms.
D000433:1-Propanol / Q000494:pharmacology*; D000588:Amines / Q000494:pharmacology; D000818:Animals; D001370:Axonal Transport; D001369:Axons / Q000378:metabolism; D001679:Biogenic Amines / Q000502:physiology; D001792:Blood Platelets / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects*; D002838:Chromaffin System / Q000378:metabolism; D003331:Coronary Vessels / Q000187:drug effects; D003374:Coumarins; D004837:Epinephrine / Q000378:metabolism; D006016:Glycolates / Q000494:pharmacology*; D006801:Humans; D009411:Nerve Endings / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D011299:Prenylamine / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000588:Amines; D001679:Biogenic Amines; D003374:Coumarins; D006016:Glycolates; D011427:Propiophenones; D014665:Vasodilator Agents; D012701:Serotonin; D000433:1-Propanol; D014700:Verapamil; D011299:Prenylamine; D009638:Norepinephrine; D004837:Epinephrine